Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-14

Clinical Trial Update: Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

View source ↗

Summary

This document summarizes a planned clinical trial assessing the combination of Ursodiol and Seladelpar for primary biliary cholangitis, with recruitment not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seladelpar (seladelpar)
  • URSODIOL (ursodiol)

Snippet

Sponsor: Methodist Health System | Conditions: Primary Biliary Cholangitis | Status: NOT_YET_RECRUITING